Richter's generic osteoporosis drug gets EU recommendation

BUDAPEST (Reuters) - Richter received a positive opinion from European regulators recommending that its generic osteoporosis drug Terrosa be granted marketing authorization, the Hungarian drug maker said in a statement on Monday.